Food and Fiber Animal Transfusion Medicine

Chapter 23
Food and Fiber Animal Transfusion Medicine


Brent C. Credille1 and Kira L. Epstein2


1Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA


2Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA


Introduction


It is important for veterinarians treating food and fiber animal species to understand the indications and techniques for transfusing whole blood and blood components. The administration of blood products is becoming more commonplace in food and fiber practice due to increases in the emotional and economic value of certain animals. This is particularly true for veterinarians that treat small ruminants and New World camelids in their practice. The type of product that is indicated will depend on the underlying cause and component of blood that is deficient. For example, in cases of thrombocytopenia or thrombocytopathia, fresh blood products are currently the only suitable choices for food and fiber animals that contain viable platelets.


In food and fiber animals, the use of stored whole blood or packed red blood cells (PRBCs) is uncommon compared to fresh whole blood (FWB) or frozen plasma (FP). The relative infrequency of blood product administration makes storage of whole blood and PRBCs impractical and the most common diseases that require blood products are usually treated with FWB and FP. FWB is indicated for the treatment of diseases associated with blood loss, such as gastrointestinal parasitism, because whole blood replaces all of the lost components. FP is indicated to replace albumin in conditions associated with severe protein loss or to provide immunoglobulins for management of failure of passive transfer (FPT) in neonates. The goal of this chapter is to review indications for blood transfusions and blood groups, as well as techniques used for the collection, processing, storage, and administration of blood products in cattle, small ruminants, New World camelids, and pigs.


Indications for transfusion of blood or blood products


Transfusion triggers


Clinicians have long sought to identify a reliable threshold for the administration of red blood cells (RBCs), a term best known as the transfusion trigger. Nevertheless, despite a wealth of research in people, a specific clearly defined transfusion trigger has not been determined. Clinical signs such as altered mentation, weakness, tachycardia, tachypnea, cool extremities, decreased pulse pressure, anuria, and pale mucous membranes (Figures 23.1 and 23.2) have been used to evaluate the hemodynamic stability of food and fiber animals (Hunt and Wood 1999; Divers 2005). In addition to clinical signs, laboratory tests are frequently used as an adjunct to evaluate tissue oxygenation. Tests most often used include packed cell volume (PCV) or hematocrit (HCT), hemoglobin (HGB) concentration, protein concentration, blood lactate concentration, anion gap, base excess, mixed venous oxygen saturation (SvO2), central venous oxygen saturation (ScvO2), and oxygen extraction ratio (O2ER) (Table 23.1) (Hunt and Wood 1999; Gutierrez et al. 2004; Divers 2005; Hurcombe et al. 2007; Carson et al. 2012a; Dellinger et al. 2013; Balcomb and Foster 2014; Nemeth et al. 2014).

c23f001

Figure 23.1 Pale ocular mucous membranes in a goat with blood loss anemia.

c23f002

Figure 23.2 Pale oral mucous membranes in a goat with blood loss anemia.


Table 23.1 Indications for the use of different blood products in food and fiber animals





















Product Indication
Whole blood Anemia (blood loss [acute and chronic], hemolysis, bone marrow suppression), thrombocytopenia/thrombocytopathia
Packed red blood cells Normovolemic anemia (hemolysis, bone marrow suppression)
Plasma Failure of passive transfer, protein losing disorders, inflammatory diseases (endotoxemia), coagulopathy, anticoagulant rodenticide toxicity
Platelet-rich plasma Thrombocytopenia/thrombocytopathia
Serum Failure of passive transfer, inflammatory disorders (endotoxemia), diseases caused by specific toxins

Historically, HGB concentration has been used as the principal transfusion trigger in human medicine and much work has revolved around establishing the appropriate HGB concentration at which to initiate a blood transfusion (Divers 2005; Carson et al. 2012a,b). Experimentally, myocardial oxygenation and cognitive ability become impaired at a HGB concentration <5 g/dL (50 g/L) or a PCV of approximately 15% (Madjdpour and Spahn 2007). At this point the risk of global tissue hypoxia and subsequent organ compromise increases. Due to risks of morbidity and mortality associated with transfusions, several studies in human medicine have evaluated liberal (HGB < 10 g/dL [100 g/L]) versus restrictive (HGB < 7 g/dL [70 g/L]) transfusion strategies, with the majority of studies favoring more restrictive criteria (Hebert et al. 1999; Vincent et al. 2002; Vallet et al. 2007; Klein et al. 2007; Napolitano et al. 2009; Carson and Kuriyan 2010; Lelubre and Vincent 2011; Carson et al. 2012a; Salpeter et al. 2014). Thus, an HGB concentration of <7 g/dL (70 g/L) is commonly used as the transfusion trigger for humans (Hebert and Tinmouth 2011).


Similar studies to determine the most appropriate HGB concentration transfusion trigger have not been performed in food and fiber animals. It has been suggested that a HGB concentration of <5 g/dL (50 g/L) could serve as a transfusion trigger in food and fiber animals (Divers 2005). Another potentially useful test for determining the need for transfusion is PCV. Clinical experience and expert opinion have led to recommendations for RBC transfusions when the PCV decreases below 15–20% in animals with acute blood loss and 10–12% in animals with chronic blood loss (Hunt and Moore 1990; Hunt and Wood 1999; Divers 2005; Balcomb and Foster 2014). The recommended PCV is lower for chronic blood loss due to adaptations the body is able to make to improve cardiac output and oxygen delivery (Divers 2005). It is important to remember that in cases of acute blood loss it can take several hours for the PCV and plasma protein to decrease, therefore these laboratory measurements might not accurately reflect the overall clinical picture or need for intervention (Mudge 2014).


In addition to the lack of information regarding appropriate HGB concentration and PCV thresholds for RBC transfusions, other laboratory tests used routinely in people have not been evaluated for use in food and fiber animals, are cost prohibitive, and are not easily adaptable to field situations because of the specialized equipment required. However, with handheld blood gas and biochemical analyzers becoming more widely available, certain parameters (e.g., base excess and lactate) might become more widely used. Table 23.2 provides some suggested cut-off values for selected clinicopathologic triggers for transfusion in food and fiber animals.


Table 23.2 Clinicopathologic triggers used to determine the need for transfusion in food and fiber animals
























Parameter Trigger point
PCV Acute blood loss: 15–20%
Chronic blood loss: 10–12%
HGB <5.0 g/dL (50 g/L)
Lactate >4 mmol/L
SvO2 <65%
ScvO2 <70%
O2ER >50%

PCV, packed cell volume; HGB, hemoglobin; SvO2, mixed venous oxygen saturation; ScvO2, central venous oxygen saturation; O2ER, oxygen extraction ratio.


Animals with comorbidities such as sepsis, cardiovascular disease, respiratory disease, or pregnancy can require transfusions at a different trigger than an animal that is otherwise healthy (Madjdpour and Spahn 2007). Therefore, the decision to transfuse RBCs should be based on a combination of factors that include the animal’s history, clinical signs, and laboratory data. Furthermore, serial measurements of the aforementioned parameters will have more value in determining the need for transfusion than measurements performed at a single time point (Tennent-Brown 2014). Thus, regular re-evaluation of the patient’s clinical status is an important part of the therapeutic plan.


Blood products


Whole blood


FWB contains multiple components, each with specific benefits: RBCs provide oxygen transport, platelets and clotting factors support hemostasis, albumin maintains colloid osmotic (oncotic) pressure, and globulins support immunity. When hemorrhage occurs, FWB is the obvious first choice blood product because it can replace all lost components. Whole blood can also be used to replace blood components to avoid time and technical issues with processing PRBC or plasma. Diseases causing bone marrow suppression or RBC lysis can result in anemia severe enough to warrant RBC replacement and whole blood transfusion can be used if PRBCs are not available. Only fresh blood products contain functional platelets for use in patients with alterations in platelet function or thrombocytopenia severe enough to result in hemorrhage. FWB can be used as an alternative to plasma in patients with coagulopathies and can be particularly beneficial if significant hemorrhage is occurring.


Packed red blood cells


PRBCs are indicated for animals with normovolemic anemia, including hemolysis, bone marrow suppression, and some cases of chronic blood loss, particularly when there is a risk for volume overload. Examples include neonates or patients with heart disease. PRBCs are used sparingly, if at all, in food and fiber animal species.


Plasma


Plasma contains numerous proteins and other soluble factors responsible for hemostasis, drug transport, immune defense, and colloid support. The primary therapeutic components of plasma include clotting factors II, V, VII, VIII, IX, X, XI, XII, and XIII, as well as albumin and immunoglobulins (Brooks 2010). Albumin is the primary oncotic protein in plasma. The primary immunoglobulin (Ig) class is IgG (>85%), with lesser amounts of IgA and IgM.


Plasma is most frequently used in food and fiber animals to supplement immunoglobulins in neonates suffering from failure of transfer of passive immunity, otherwise known as FPT. Plasma can also be used to provide oncotic support in animals with diseases that cause severe hypoproteinemia. Use of plasma for oncotic support is performed commonly and successfully in horses (Tennent-Brown 2011). Personal experience and logic suggest that a similar effect would be seen in ruminants and swine. Another common use for plasma, particularly hyperimmune products, is to provide support for animals with severe inflammatory disorders. Hyperimmune products theoretically provide antibodies directed at the core portion of the lipopolysaccharide (LPS) molecule, making it unavailable for interaction with immune cells and reducing clinical manifestations of disease (Morris et al. 1986a,b). Plasma can also be used to provide coagulation factors in cases of anticoagulant rodenticide toxicity, ongoing hemorrhage, and other coagulopathies.


Failure of passive transfer


FPT in food and fiber animals is diagnosed by a variety of direct and indirect methods (Tyler et al. 1999). Radial immunodiffusion (RID) is the gold standard method for assessing passive transfer status and directly measures IgG in serum, with any value <1000 mg/dL (10 g/L) indicating FPT. RID can be performed using commercially available kits but requires a period of 24 hours before results are available. Numerous indirect techniques designed to assess passive transfer status exist and include the sodium sulfite turbidity test, zinc sulfate turbidity test, and whole blood glutaraldehyde coagulation test (Tyler et al. 1999). One of the more common indirect techniques used to assess passive transfer status in neonatal calves and crias is measurement of serum total solids (TS) concentration by refractometry. In calves, a TS <5.2 g/dL (52 g/L) is indicative of FPT, while in crias a value of <5.0 g/dL (50 g/L) should be used (Tyler et al. 1999; Weaver et al. 2000).


Recently, estimation of serum IgG in neonatal calves was evaluated using a Brix refractometer (Deelen et al. 2014). Using a value of 8.4% Brix, the sensitivity and specificity of the test were both 88.9%, making this test a viable alternative for assessing passive transfer status in calves (Deelen et al. 2014). Neonatal calves with FPT suffer from an increased risk of mortality during the first 12 weeks of life and have decreased rates of gain and lower milk production as compared to healthy controls (Wittum and Perino 1995). Thus, plasma is likely indicated to supplement immunoglobulins and reduce the risk of neonatal and post-weaning disease and death in more valuable food and fiber animals with FPT (Figure 23.3). Unfortunately, little evidence regarding the efficacy of plasma in preventing disease in food and fiber animals with FPT exists in the peer-reviewed literature.

c23f003

Figure 23.3 Plasma labeled with appropriate species, gender, identification, date of collection, volume, and sedatives used is stored frozen for use in the case of failure of passive transfer.


(Courtesy of Kenichiro Yagi, BS, RVT, VTS (ECC, SAIM).)


Hypoproteinemia


In animals with protein losing disorders, a total plasma protein below 3.0 g/dL (30 g/L) or a serum albumin below 1.5 g/dL (15 g/L) increases the risk of tissue and organ edema, suggesting these values might be a reasonable cut-off to consider administration of plasma to affected animals (Hunt and Wood 1999; Divers 2005; Brooks 2010). Unfortunately, no evidence exists to either support or refute the use of plasma for this purpose. Generally, the high cost of transfusions and high volumes of plasma required to raise total plasma protein concentrations are limiting factors in the use of plasma in food and fiber animal species.


Serum


Serum is the component of blood separated after clotting has occurred. Unfortunately, little work has been done to evaluate the effect of serum or serum products on the health of food and fiber animals. Several available products contain antibodies against Pasteurella spp., Trueperella pyogenes, E. coli, Salmonella spp., and Clostridium perfringens type C and D (Anonymous 2013). However, there is little data to confirm the effectiveness of these products in clinical situations. Studies performed in calves in the late 1980s using LPS infusions found that an antiserum directed at a mutant E. coli did not mitigate the effects of LPS on any clinical parameters tested (Morris et al. 1986a,b). More recently, a study evaluated the ability of serum to increase IgG in calves with FPT and found that the administration of 500 mL of a commercially available serum product significantly increased serum protein concentrations, but had no effect on serum IgG concentration. In addition, the proportion of calves with FPT after transfusion was 82%, making this product an unacceptable source of IgG for calves with FPT (Chigerwe and Tyler 2010). Therefore, the use of serum or hyperimmune serum products in food and fiber animals cannot be supported.


Donor selection


Donors should be selected based on the health and size of the donor, and screened to avoid transmission of bloodborne disease. In general, female and multiparous animals present a higher risk of causing transfusion reactions because of antigen exposure during pregnancy (Mudge 2010). All donors should have a PCV and total protein within the reference range for the species of interest; larger animals are able to give larger volumes of blood more safely. Bloodborne infections that should be screened for in cattle include bovine viral diarrhea virus (BVDV), bovine leukosis virus (BLV), brucellosis, tuberculosis, and paratuberculosis; in small ruminants, caprine arthritis encephalitis virus (CAE), scrapie, brucellosis, Coxiella burnetti, and Corynebacterium pseuotuberculosis; and in New World camelids, Mycoplasma haemolamae (Balcomb and Foster 2014).


Blood groups and types


Blood group antigens are glycoproteins and glycolipids located on the surface of RBCs (Reid and Mohandas 2004). These antigens provide membrane structural integrity and membrane molecular transport as receptors for extracellular ligands, as adhesion molecules, for recognition of self by the immune system, and, in some cases, as genetic markers (Reid and Mohandas 2004). In ruminants, blood groups are detected by hemolytic tests because the RBCs of these species are not prone to agglutination (Divers 2005; Andrews and Penedo 2010). Porcine blood groups can be detected by either agglutination or hemolytic tests (Andrews and Penedo 2010). Food and fiber animals rarely have naturally occurring alloantibodies to the species blood groups that the individual animal does not have, making the risk of a reaction to a first transfusion in these patients low (Divers 2005; Andrews and Penedo 2010; Balcomb and Foster 2014). Nevertheless, transfusion reactions do occur and an understanding of the various blood groups and types in food and fiber animals is necessary. Indeed, should a patient require additional transfusions during treatment, crossmatching is recommended as sensitization does occur and can affect the lifespan of the transfused cells, the systemic health of the patient, or both. Historically, a single letter designation has been used to denote particular blood group systems in livestock species. The more recent nomenclature convention is to precede the specific system with the letters EA (erythrocyte antigen) and this is the terminology used in the rest of the chapter. Table 23.3 summarizes blood groups recognized in food and fiber animals.


Table 23.3 Blood groups in food and fiber animals





















Species Blood groups
Cattle EAA, EAB, EAC, EAF, EAJ, EAL, EAM, EAR, EAS, EAT, EAZ
Sheep EAA, EAB, EAC, EAD, EAM, EAR, EAX
Goats EAA, EAB, EAC, EAE, EAF, EAR
New World camelids EAA, EAB, EAC, EAD, EAE, EAF
Pigs EAA, EAB, EAC, EAD, EAE, EAF, EAG, EAH, EAI, EAJ, EAK, EAL, EAM, EAN, EAO, EAP

EA, erythrocyte antigen.


Cattle


Studies investigating the blood groups of cattle began in the 1940s and served as a model for the investigation and determination of blood groups in other food and fiber species. Eleven major blood groups have been identified in cattle: EAA, EAB, EAC, EAF, EAJ, EAL, EAM, EAR, EAS, EAT, and EAZ (Stormont 1962; Andrews and Penedo 2010). In addition to the 11 blood groups, more than 70 blood group factors have been identified, with most of the variation found in the EAB and EAC systems (Andrews and Penedo 2010). The EAJ antigen, unlike other blood group antigens, is a glycolipid antigen found in plasma, only attaching to RBCs when sufficiently high concentrations are present (Andrews and Penedo 2010; Balcomb and Foster 2014). It is important to note that cattle that are J antigen negative can have naturally occurring anti-J antibodies in circulation and should an EAJ negative cow be transfused with blood from an EAJ positive donor significant reactions could occur (Divers 2005).


Sheep


Eight blood group systems have been described in sheep including EAA, EAB, EAC, EAD, EAM, EAR, and EAX (Stormont 1982; Andrews and Penedo 2010). Additionally, 22 different blood group factors are recognized, with the most variation found in the EAB system. The R antigen, like the J antigen in cattle, is found in plasma and only bound to the RBC membrane when in high concentrations (Andrews and Penedo 2010).


Goats


Blood group systems in goats are far less understood than those in other food and fiber animal species. Six blood group systems have been identified so far: EAA, EAB, EAC, EAE, EAF, and EAR. The R antigen is analogous to the R antigen found in sheep (Nguyen 1990).


Pigs


Sixteen blood groups systems have been identified in pigs: EAA, EAB, EAC, EAD, EAE, EAF, EAG, EAH, EAI, EAJ, EAK, EAL, EAM, EAN, EAO, and EAP (Stormont 1982; Andrews and Penedo 2010). Groups E and M are similar to groups B and C in cattle in that the majority of antigen diversity is found in these groups. Antigens A and O are soluble compounds in the serum and saliva of A and O positive animals, respectively. They attach to the RBC membrane within the first few weeks after birth (Andrews and Penedo 2010).


New World camelids: llamas and alpacas


Six blood groups systems have been identified in New World camelids: EAA, EAB, EAC, EAD, EAE, and EAF (Penedo et al. 1988). Unfortunately, little is known about blood group variation in these animals.


Screening for blood group compatibility

Stay updated, free articles. Join our Telegram channel

Sep 27, 2017 | Posted by in GENERAL | Comments Off on Food and Fiber Animal Transfusion Medicine

Full access? Get Clinical Tree

Get Clinical Tree app for offline access